The promises and challenges of the use of genomics in the prescription of exercise for hypertension: The 2013 update

Current Hypertension Reviews

Volumn 9, Issue 2, 2013, Pages 130-147

  Ash, Garrett I ^a   Eicher, John D ^b   Pescatello, Linda S ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Genetics; Physical activity; Polymorphisms; Pre hypertension

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ALDOSTERONE SYNTHASE; ALPHA ADDUCIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; C REACTIVE PROTEIN; CHOLINERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FIBRINOGEN; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICRORNA; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA1;

AEROBIC EXERCISE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; FAMILY HISTORY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INDEL MUTATION; KINESIOTHERAPY; METABOLIC SYNDROME X; NONHUMAN; PHENOTYPE; POST EXERCISE HYPOTENSION; PRESCRIPTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; EXERCISE; EXERCISE THERAPY; GENOMICS; HUMANS; HYPERTENSION; INDIVIDUALIZED MEDICINE; POLYMORPHISM, GENETIC;

EID: 84881539881     PISSN: 15734021     EISSN: 18756506     Source Type: Journal    
DOI: 10.2174/15734021113099990010     Document Type: Article

References (136)

1. Arima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens 2011; 29(1): S3-7.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013; 127(1): e6-e245.
3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-1252.
4. Staessen JA, Wang JG, Birkenhager WH. Outcome beyond blood pressure control? Eur Heart J 2003; 24(6): 504-514.
5. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123(8): 933-944.
6. Pescatello LS, Franklin BA, Fagard R, et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36(3): 533-553.
7. Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005; 46(4): 667-675.
8. Fagard RH, Cornelissen VA. Effect of exercise on blood pressure control in hypertensive patients. Eur J Cardiovasc Prev Rehabil 2007; 14(1):12-17.
9. Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 2001; 33(6 Suppl): S484-92; discussion S493-4.
10. Kelley GA, Kelley KA, Tran ZV. Aerobic exercise and resting blood pressure: a meta-analytic review of randomized, controlled trials. Prev Cardiol 2001; 4(2): 73-80.
11. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136(7): 493-503.
12. Fagard RH. Effects of exercise, diet and their combination on blood pressure. J Hum Hypertens 2005; 19(3): S20-4.
13. Fagard RH. Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol 2006; 33(9): 853-856.
14. Cornelissen VA, Buys R, Smart NA. Endurance exercise beneficially affects ambulatory blood pressure: a systematic review and meta-analysis. J Hypertens 2013; 31(4): 639-648.
15. Hagberg JM, Brown MD. Does exercise training play a role in the treatment of essential hypertension? J Cardiovasc Risk 1995; 2(4): 296-302.
16. Hagberg JM, Park JJ, Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med 2000; 30(3): 193-206.
17. Pescatello LS, Kulikowich JM. The aftereffects of dynamic exercise on ambulatory blood pressure. Med Sci Sports Exerc 2001; 33(11):1855-1861.
18. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc 2001; 33(6): S446-51; discussion S452-3.
19. Jennings GL, Deakin G, Korner P, Meredith I, Kingwell B, Nelson L. What is the dose-response relationship between exercise training and blood pressure? Ann Med 1991; 23(3): 313-318.
20. Meredith IT, Jennings GL, Esler MD, et al. Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens 1990; 8(9): 859-866.
21. Murray A, Delaney T, Bell C. Rapid onset and offset of circulatory adaptations to exercise training in men. J Hum Hypertens 2006; 20(3): 193-200.
22. Hagberg JM. Interactive Effects of Genetics and Acute Exercise and Exercise Training on Plasma Lipoprotein Lipid and Blood Pressure Phenotypes. In: Pescatello LS, Roth SM, editors. Exercise Genomics New York, NY: Springer; 2011. p. 129-156.
23. Pescatello LS, Blanchard BE, Tsongalis GJ, et al. A comparison of the genetic and clinical profile of men that respond and do not respond to the immediate antihypertensive effects of aerobic exercise. Application of Clinical Genetics 2008; 1: 7-17.
24. Bouchard C, Blair SN, Church TS, et al. Adverse metabolic response to regular exercise: is it a rare or common occurrence? PLoS One 2012; 7(5): e37887.
25. Pescatello LS. The promises and challenges of the use of genomics in the prescription of exercise in hypertension. Current Hypertension Reviews 2010; 6(1): 32-43.
26. Pescatello LS, Roth SM editors. Exercise Genomics. New York, NY: Springer; 2011.
27. Hagberg JM. Do genetic variations alter the effects of exercise training on cardiovascular disease and can we identify the candidate variants now or in the future? J Appl Physiol 2011; 111(3): 916-928.
28. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 2005; 7(2): 102-109.
29. Olson KM, Augeri AL, Seip RL, Tsongalis GJ, Thompson PD, Pescatello LS. Correlates of endothelial function and the peak systolic blood pressure response to a graded maximal exercise test. Atherosclerosis 2012; 222(1): 202-207.
30. Augeri AL, Tsongalis GJ, Van Heest JL, Maresh CM, Thompson PD, Pescatello LS. The endothelial nitric oxide synthase-786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis 2009; 204(2): e28-34.
31. Eicher JD, Maresh CM, Tsongalis GJ, Thompson PD, Pescatello LS. The additive blood pressure lowering effects of exercise intensity on post-exercise hypotension. Am Heart J 2010; 160(3): 513-520.
32. Santana HA, Moreira SR, Neto WB, et al. The higher exercise intensity and the presence of allele I of ACE gene elicit a higher post-exercise blood pressure reduction and nitric oxide release in elderly women: an experimental study. BMC Cardiovasc Disord 2011; 11: 71-2261-11-71.
33. Alioglu E, Ercan E, Tengiz I, et al. The influence of alpha-adducin gene polymorphism on response of blood pressure to exercise in patients with hypertension. Anadolu Kardiyol Derg 2010; 10(5): 400-404.
34. Fitzgerald W. Labile hypertension and jogging: new diagnostic tool or spurious discovery? Br Med J (Clin Res Ed) 1981; 282(6263): 542-544.
35. Halliwill JR. Mechanisms and clinical implications of postexercise hypotension in humans. Exerc Sport Sci Rev 2001; 29(2): 65-70.
36. Haskell WL. J.B. Wolffe Memorial Lecture. Health consequences of physical activity: understanding and challenges regarding doseresponse. Med Sci Sports Exerc 1994; 26(6): 649-660.
37. Thompson PD, Crouse SF, Goodpaster B, Kelley D, Moyna N, Pescatello L. The acute versus the chronic response to exercise. Med Sci Sports Exerc 2001; 33(6): S438-45; discussion S452-3.
38. Wilcox RG, Bennett T, Brown AM, Macdonald IA. Is exercise good for high blood pressure? Br Med J (Clin Res Ed) 1982; 285(6344): 767-769.
39. Liu S, Goodman J, Nolan R, Lacombe S, Thomas S. Blood Pressure Responses to Acute and Chronic Exercise are Related in Prehypertensives. Med Sci Sports Exerc 2012.
40. Maeda S, Tanabe T, Otsuki T, Sugawara J, Ajisaka R, Matsuda M. Acute exercise increases systemic arterial compliance after 6-month exercise training in older women. Hypertens Res 2008; 31(2): 377-381.
41. Tabara Y, Yuasa T, Oshiumi A, et al. Effect of acute and long-term aerobic exercise on arterial stiffness in the elderly. Hypertens Res 2007; 30(10): 895-902.
42. da Nobrega AC. The subacute effects of exercise: concept, characteristics, and clinical implications. Exerc Sport Sci Rev 2005; 33(2): 84-87.
43. Hecksteden A, Grutters T, Meyer T. Association between postexercise hypotension and long-term training-induced blood pressure reduction: a pilot study. Clin J Sport Med 2013; 23(1): 58-63.
44. Halliwill JR, Buck TM, Lacewell AN, Romero SA. Postexercise hypotension and sustained postexercise vasodilatation: what happens after we exercise? Exp Physiol 2013; 98(1): 7-18.
45. Sponton CH, Rezende TM, Mallagrino PA, Franco-Penteado CF, Bezerra MA, Zanesco A. Women with TT genotype for eNOS gene are more responsive in lowering blood pressure in response to exercise. Eur J Cardiovasc Prev Rehabil 2010; 17(6): 676-681.
46. Zago AS, Park JY, Fenty-Stewart N, Kokubun E, Brown MD. Effects of aerobic exercise on the blood pressure, oxidative stress and eNOS gene polymorphism in pre-hypertensive older people. Eur J Appl Physiol 2010; 110(4): 825-832.
47. Esposti RD, Sponton CH, Malagrino PA, et al. Influence of eNOS gene polymorphism on cardiometabolic parameters in response to physical training in postmenopausal women. Braz J Med Biol Res 2011; 44(9): 855-863.
48. Zago AS, Kokubun E, Fenty-Stewart N, et al. Effect of physical activity and t-786C polymorphism in blood pressure and blood flow in the elderly. Arq Bras Cardiol 2010; 95(4): 510-516.
49. Rezende TM, Sponton CH, Malagrino PA, Bezerra MA, Penteado CF, Zanesco A. Effect of exercise training on the cardiovascular and biochemical parameters in women with eNOS gene polymorphism. Arch Physiol Biochem 2011; 117(5): 265-269.
50. Rankinen T, Rice T, Leon AS, Skinner JS, Wilmore JH, Rao DC, et al. G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics 2002; 8(2): 151-157.
51. Rankinen T, Church T, Rice T, et al. Effect of endothelin 1 genotype on blood pressure is dependent on physical activity or fitness levels. Hypertension 2007; 50(6):1120-1125.
52. Rankinen T, Rice T, Perusse L, et al. NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension 2000; 36(5): 885-889.
53. Rankinen T, Gagnon J, Perusse L, et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279(1): H368-74.
54. Rankinen T, Bouchard C. Genetics and blood pressure response to exercise, and its interactions with adiposity. Prev Cardiol 2002 Summer; 5(3): 138-144.
55. Ford ES, Zhao G, Li C, Pearson WS, Mokdad AH. Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States. Am J Hypertens 2008; 21(10): 1124-1128.
56. Mellen PB, Gao SK, Vitolins MZ, Goff DC, Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med 2008; 168(3): 308-314.
57. Churilla JR, Ford ES. Comparing physical activity patterns of hypertensive and nonhypertensive US adults. Am J Hypertens 2010; 23(9): 987-993.
58. Pescatello LS, Blanchard BE, Tsongalis GJ, Maresh CM, Griffiths B, Thompson PD. The GNAS 393 T>C polymorphism and the blood pressure response immediately following aerobic exercise among men with elevated blood pressure. Vasc Dis Prev 2009(6): 56-64.
59. Pescatello LS, Blanchard BE, Tsongalis GJ, Maresh CM, O'Connell A, Thompson PD. The alpha-adducin Gly460Trp polymorphism and the antihypertensive effects of exercise among men with high blood pressure. Clin Sci (Lond) 2007; 113(5): 251-258.
60. Blanchard BE, Tsongalis GJ, Guidry MA, LaBelle LA, Poulin M, Taylor AL, et al. RAAS polymorphisms alter the acute blood pressure response to aerobic exercise among men with hypertension. Eur J Appl Physiol 2006; 97(1): 26-33.
61. Staessen JA, Bianchi G. Adducin and hypertension. Pharmacogenomics 2005; 6(7): 665-669.
62. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism: detection and impact on hypertension and related disorders. Hypertension 2005; 45(3): 331-340.
63. Volpe M, Musumeci B, De Paolis P, Savoia C, Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 2003; 21(8): 1429-1443.
64. Staessen JA, Wang JG, Brand E, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19(8): 1349-1358.
65. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care 1991; 14(3): 195-202.
66. Miller AW, Tulbert C, Puskar M, Busija DW. Enhanced endothelin activity prevents vasodilation to insulin in insulin resistance. Hypertension 2002; 40(1): 78-82.
67. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23(5): 469-480.
68. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48(5): 787-796.
69. Kren V, Qi N, Krenova D, et al. Y-chromosome transfer induces changes in blood pressure and blood lipids in SHR. Hypertension 2001; 37(4): 1147-1152.
70. Negrin CD, McBride MW, Carswell HV, et al. Reciprocal consomic strains to evaluate y chromosome effects. Hypertension 2001; 37(2 Part 2): 391-397.
71. Poveda JJ, Riestra A, Salas E, et al. Contribution of nitric oxide to exercise-induced changes in healthy volunteers: effects of acute exercise and long-term physical training. Eur J Clin Invest 1997; 27(11): 967-971.
72. Bode-Boger SM, Boger RH, Schroder EP, Frolich JC. Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk 1994; 1(2): 173-178.
73. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333(6174): 664-666.
74. Yang Z, Wang JM, Chen L, Luo CF, Tang AL, Tao J. Acute exercise-induced nitric oxide production contributes to upregulation of circulating endothelial progenitor cells in healthy subjects. J Hum Hypertens 2007; 21(6): 452-460.
75. Zago AS, Zanesco A. Nitric oxide, cardiovascular disease and physical exercise. Arq Bras Cardiol 2006; 87(6): e264-70.
76. Santana HA, Moreira SR, Asano RY, et al. Exercise intensity modulates nitric oxide and blood pressure responses in hypertensive older women. Aging Clin Exp Res 2013; 25(1): 43-48.
77. Higashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endotheliumderived nitric oxide. Circulation 1999; 100(11): 1194-1202.
78. Moriguchi J, Itoh H, Harada S, et al. Low frequency regular exercise improves flow-mediated dilatation of subjects with mild hypertension. Hypertens Res 2005; 28(4): 315-321.
79. Nakayama M, Yasue H, Yoshimura M, et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999 Jun 8;99(22):2864-2870.
80. Colombo MG, Paradossi U, Andreassi MG, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 2003; 49(3): 389-395.
81. Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 2006; 41(7): 1044-1049.
82. Souza-Costa DC, Sandrim VC, Lopes LF, Gerlach RF, Rego EM, Tanus-Santos JE. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. Atherosclerosis 2007; 193(2): 438-444.
83. Tzemos N, Lim PO, MacDonald TM. Is exercise blood pressure a marker of vascular endothelial function? QJM 2002; 95(7): 423-429.
84. Miyai N, Arita M, Morioka I, Miyashita K, Nishio I, Takeda S. Exercise BP response in subjects with high-normal BP: exaggerated blood pressure response to exercise and risk of future hypertension in subjects with high-normal blood pressure. J Am Coll Cardiol 2000; 36(5): 1626-1631.
85. Hagberg JM, Rankinen T, Loos RJ, Perusse L, Roth SM, Wolfarth B, et al. Advances in exercise, fitness, and performance genomics in 2010. Med Sci Sports Exerc 2011; 43(5): 743-752.
86. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461(7265): 747-753.
87. Balam-Ortiz E, Esquivel-Villarreal A, Huerta-Hernandez D, et al. Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension. Hypertension 2012; 59(4): 847-853.
88. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012; 109(4): 1193-1198.
89. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007; 80(3): 531-538.
90. Cowley AW, Jr, Nadeau JH, Baccarelli A, et al. Report of the national heart, lung, and blood institute working group on epigenetics and hypertension. Hypertension 2012; 59(5): 899-905.
91. Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet 2010; 3(6): 567-573.
92. Bouchard C. Overcoming barriers to progress in exercise genomics. Exerc Sport Sci Rev 2011; 39(4): 212-217.
93. Roth SM. Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104(4): 1243-1245.
94. Baldwin KM, Haddad F. Research in the exercise sciences: where we are and where do we go from here--Part II. Exerc Sport Sci Rev 2010; 38(2): 42-50.
95. Pescatello LS. Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008; 104(4):1247.
96. Shendure J, Lieberman Aiden E. The expanding scope of DNA sequencing. Nat Biotechnol 2012; 30(11): 1084-1094.
97. Kostek MA, Angelopoulos TJ, Clarkson PM, et al. Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. Med Sci Sports Exerc 2009; 41(5): 1063-1071.
98. Clarkson PM, Devaney JM, Gordish-Dressman H, et al. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 2005; 99(1): 154-163.
99. Turner ST, Bailey KR, Schwartz GL, Chapman AB, Chai HS, Boerwinkle E. Genomic Association Analysis Identifies Multiple Loci Influencing Antihypertensive Response to an Angiotensin II Receptor Blocker. Hypertension 2012; 59(6): 1204-1211.
100. Watkins WS, Hunt SC, Williams GH, et al. Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens 2010; 28(1): 65-75.
101. Roth SM, Rankinen T, Hagberg JM, et al. Advances in Exercise, Fitness, and Performance Genomics in 2011. Med Sci Sports Exerc 2012.
102. Bouchard C, Sarzynski MA, Rice TK, et al. Genomic predictors of the maximal O uptake response to standardized exercise training programs. J Appl Physiol 2011; 110(5): 1160-1170.
103. Rankinen T, Sung YJ, Sarzynski MA, Rice TK, Rao DC, Bouchard C. Heritability of submaximal exercise heart rate response to exercise training is accounted for by nine SNPs. J Appl Physiol 2012; 112(5): 892-897.
104. Ash GI, Augeri AL, Eicher JD, Bruneau Jr. ML, Pescatello LS. A Prioritized Panel of Candidate Genes to be explored for Associations with the Blood Pressure Response to Exercise. In: Urbano KB, editor. Advances in Genetics Research. Volume 9 Hauppage, NY: Nova; 2012.
105. DE Moor MH, Liu YJ, Boomsma DI, et al. Genome-Wide Association Study of Exercise Behavior in Dutch and American Adults. Med Sci Sports Exerc 2009.
106. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008; 3(10): e3583.
107. Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 2011; 89(1): 82-93.
108. Schifano ED, Li L, Christiani DC, Lin X. Genome-wide Association Analysis for Multiple Continuous Secondary Phenotypes. Am J Hum Genet 2013; 92(5): 744-759.
109. Padmanabhan S. Prospects for genetic risk prediction in hypertension. Hypertension 2013; 61(5): 961-963.
110. Havulinna AS, Kettunen J, Ukkola O, Osmond C, Eriksson JG, Kesaniemi YA, et al. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 2013; 61(5): 987-994.
111. Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007; 316(5830): 1497-1502.
112. Jacobs C, Segre D. Organization principles in genetic interaction networks. Adv Exp Med Biol 2012; 751: 53-78.
113. Bray MS, Hagberg JM, Perusse L, et al. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc 2009; 41(1): 35-73.
114. Delmonico MJ, Ferrell RE, Meerasahib A, et al. Blood pressure response to strength training may be influenced by angiotensinogen A-20C and angiotensin II type I receptor A1166C genotypes in older men and women. J Am Geriatr Soc 2005; 53(2): 204-210.
115. Hagberg JM, Ferrell RE, Dengel DR, Wilund KR. Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent. Hypertension 1999; 34(1): 18-23.
116. Rauramaa R, Kuhanen R, Lakka TA, et al. Physical exercise and blood pressure with reference to the angiotensinogen M235T polymorphism. Physiol Genomics 2002; 10(2):71-77.
117. Zhang B, Sakai T, Miura S, et al. Association of angiotensinconverting-enzyme gene polymorphism with the depressor response to mild exercise therapy in patients with mild to moderate essential hypertension. Clin Genet 2002; 62(4): 328-333.
118. Feairheller DL, Brown MD, Park JY, et al. Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension. Med Sci Sports Exerc 2009; 41(7): 1421-1428.
119. Flavell DM, Wootton PT, Myerson SG, et al. Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth. J Mol Med 2006; 84(2): 126-131.
120. de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects. Ann Nutr Metab 2006; 50(4): 354-360.
121. Kilpelainen TO, Lakka TA, Laaksonen DE, et al. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study. Metabolism 2008; 57(3): 428-436.
122. Pescatello LS, Blanchard BE, Van Heest JL, Maresh CM, Gordish-Dressman H, Thompson PD. The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design. BMC Cardiovasc Disord 2008; 8: 12.
123. Fernandes T, Magalhaes FC, Roque FR, Phillips MI, Oliveira EM. Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16,-21, and-126. Hypertension 2012; 59(2): 513-520.
124. Batkai S, Thum T. MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep 2012; 14(1): 79-87.
125. Makar KW, Wilson CB. DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 2004; 173(7): 4402-4406.
126. Chen Z, Karaplis AC, Ackerman SL, et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 2001; 10(5): 433-443.
127. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004; 279(28): 29147-29154.
128. Turunen MP, Aavik E, Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 2009; 1790(9): 886-891.
129. Smolarek I, Wyszko E, Barciszewska AM, et al. Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 2010; 16(3): CR149-155.
130. Friso S, Pizzolo F, Choi SW, et al. Epigenetic control of 11 betahydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 2008; 199(2): 323-327.
131. Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003; 21(3): 255-261.
132. Keller P, Vollaard NB, Gustafsson T, et al. A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol 2011; 110(1): 46-59.
133. Timmons JA, Knudsen S, Rankinen T, et al. Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol 2010; 108(6): 1487-1496.
134. Phillips BE, Williams JP, Gustafsson T, et al. Molecular networks of human muscle adaptation to exercise and age. PLoS Genet 2013; 9(3): e1003389.
135. Lightfoot JT. Current understanding of the genetic basis for physical activity. J Nutr 2011; 141(3): 526-530.
136. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991; 78(3): 691-692.